New oral drug treatment for some advanced breast cancer
The FDA has approved a new oral drug for the treatment of HR-positive, HER2-negative advanced breast cancer. A companion blood test was also approved to help doctors identify patients who […]
About Dana Mooney
This author has not written his bio yet.
But we are proud to say that Dana Mooney contributed 55 entries already.
Entries by Dana Mooney
New Drug Approved to Treat Metastatic Breast Cancer Patients with ESR1 Mutations
/in NewsInnovative drug offers a novel option for those living with ER+, HER2- metastatic breast cancer The U.S. Food and Drug Administration has just approved its first new hormone therapy in […]
Trodelvy benefits people with advanced hormone-positive metastatic breast cancer
/in FORCE Syndicated Content, NewsThe study TROPiCS-2 showed that the drug Trodelvy (sacituzumab govitecan) improved progression-free survival when compared to chemotherapy in people with advanced metastatic ER/PR-positive, HER2-negative breast cancer who have few other […]
Black Women and Breast Cancer: Why Disparities Persist and How to End Them
/in MBCA Member - BCRF, ResearchMore progress needs to be made to improve outcomes for Black women with breast cancer. Here’s how BCRF investigators are addressing the challenge. In the United States, breast cancer continues […]
Breast cancer vaccine trial begins enrolling people with BRCA1 and PALB2 mutations
/in FORCE Syndicated Content, NewsA new vaccine was first tested on people diagnosed with triple-negative breast cancer. The vaccine is now being tested to prevent breast cancer among people with an inherited mutation in […]
Metastatic Breast Cancer Alliance
28 West 44th Street
Suite 609
New York, NY 10036